MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--Rainbow Coral Corp. (RBCC) is taking full advantage of more research-friendly regulations north of the border to target new personalized medicine opportunities in Canada. These opportunities include marketing cutting-edge treatments utilizing adult stem cells and the reprogramming of a patient’s own existing cells to combat a variety of diseases, such as multiple sclerosis, ALS (Lou Gehrig’s disease) and Parkinson’s. “The Canadian regulatory environment is
| < Prev | Next > |
|---|
